Role of Lopinavir/Ritonavir in the Treatment of Covid-19: A Review of Current Evidence, Guideline Recommendations, and Perspectives

A life-threatening respiratory illness (COVID-19) due to severe acute respiratory syndrome (SARS)-CoV-2 coronavirus was first described in December 2019 in Wuhan (China), rapidly evolving into a pandemic. In the first phase, when the viral replication plays a pivotal pathogenetic role, antiviral dru...

Descripción completa

Detalles Bibliográficos
Autores principales: Meini, Simone, Pagotto, Alberto, Longo, Benedetta, Vendramin, Igor, Pecori, Davide, Tascini, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408758/
https://www.ncbi.nlm.nih.gov/pubmed/32629768
http://dx.doi.org/10.3390/jcm9072050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408758/
https://www.ncbi.nlm.nih.gov/pubmed/32629768
http://dx.doi.org/10.3390/jcm9072050

Ejemplares similares